CD274 and neuroblastoma: If the reviewed computational model of PD-L1 expression [34] was incorporated into every neuroblastoma cell agent and new agents were added to represent immune cells, the updated multicellular model could be used to evaluate PD-1 and PD-L1 inhibitors.